ClariVest Asset Management’s Merck MRK Stock Holding History

ClariVest Asset Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$8.92K	Hold	71	–	–	﹤0.01%	422
2024 Q2	$8.92K	Sell	71 -35	-33%	-$4.51K	﹤0.01%	422
2024 Q1	$14K	Buy	106 +47	+80%	+$5.79K	﹤0.01%	397
2023 Q4	$6.43K	Sell	59 -20	-25%	-$2.08K	﹤0.01%	431
2023 Q3	$8K	Sell	79 -152,960	-100%	-$16.5M	﹤0.01%	411
2023 Q2	$17.7M	Sell	153,039 -28,396	-16%	-$3.22M	0.89%	19
2023 Q1	$19.3M	Sell	181,435 -10	-0%	-$1.08K	0.86%	22
2022 Q4	$20.1M	Sell	181,445 -4,734	-3%	-$484K	0.97%	21
2022 Q3	$16M	Sell	186,179 -8,300	-4%	-$741K	0.77%	26
2022 Q2	$17.7M	Buy	194,479 +194,456	+845,461%	+$17.2M	0.77%	29
2022 Q1	$2K	Hold	23	–	–	﹤0.01%	588
2021 Q4	$2K	Hold	23	–	–	﹤0.01%	635
2021 Q3	$2K	Sell	23 -2,500	-99%	-$190K	﹤0.01%	634
2021 Q2	$196K	Sell	2,523 -121	-5%	-$9K	0.01%	477
2021 Q1	$195K	Sell	2,644 -160	-6%	-$11.8K	0.01%	474
2020 Q4	$219K	Sell	2,804 -708	-20%	-$54.1K	0.01%	484
2020 Q3	$278K	Sell	3,512 -386,706	-99%	-$30.3M	0.01%	426
2020 Q2	$28.8M	Sell	390,218 -157,116	-29%	-$11.8M	0.79%	28
2020 Q1	$40.2M	Sell	547,334 -37,453	-6%	-$2.94M	1.2%	22
2019 Q4	$50.7M	Sell	584,787 -56,448	-9%	-$4.64M	1.16%	15
2019 Q3	$51.5M	Sell	641,235 -30,014	-4%	-$2.41M	1.16%	16
2019 Q2	$53.7M	Sell	671,249 -47,050	-7%	-$3.6M	1.21%	13
2019 Q1	$57M	Sell	718,299 -48,632	-6%	-$3.64M	1.15%	15
2018 Q4	$55.9M	Sell	766,931 -34,102	-4%	-$2.41M	1.2%	14
2018 Q3	$54.2M	Sell	801,033 -56,688	-7%	-$3.61M	0.96%	20
2018 Q2	$49.7M	Buy	857,721 +852,073	+15,086%	+$48.1M	0.86%	27
2018 Q1	$294K	Sell	5,648 -330	-6%	-$17.8K	0.01%	560
2017 Q4	$321K	Buy	5,978 +502	+9%	+$27.8K	0.01%	537
2017 Q3	$335K	Sell	5,476 -214	-4%	-$13K	0.01%	430
2017 Q2	$348K	Sell	5,690 -115	-2%	-$7K	0.01%	425
2017 Q1	$352K	Sell	5,805 -118	-2%	-$7.16K	0.01%	423
2016 Q4	$332K	Buy	5,923 +2,563	+76%	+$150K	0.01%	441
2016 Q3	$200K	Buy	3,360 +1,413	+73%	+$82.6K	0.01%	493
2016 Q2	$107K	Hold	1,947	–	–	﹤0.01%	517
2016 Q1	$98K	Hold	1,947	–	–	﹤0.01%	513
2015 Q4	$98K	Buy	1,947 +144	+8%	+$7.26K	﹤0.01%	509
2015 Q3	$85K	Buy	+1,803	New	+$95.8K	﹤0.01%	484
2014 Q2	–	Sell	-41	Closed	-$2K	–	600
2014 Q1	$2K	Buy	+41	New	+$2.12K	﹤0.01%	536
2013 Q3	–	Sell	-27	Closed	-$1K	–	583
2013 Q2	$1K	Buy	+27	New	+$1.21K	﹤0.01%	509

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClariVest Asset Management's MRK Position: Q3 2024 in Review

ClariVest Asset Management held its Merck (MRK) position steady in Q3 2024 at 71 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

ClariVest Asset Management first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. The position peaked at $57M in Q1 2019. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

ClariVest Asset Management held 71 shares of Merck worth $8.92K as of Q3 2024.
ClariVest Asset Management left its Merck share count unchanged in Q3 2024.
Merck made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #422 holding.
ClariVest Asset Management first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
ClariVest Asset Management's Merck position peaked at $57M in Q1 2019.
3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.